Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on INSPIRED ENERGY PLC. We currently have 22 research reports from 5 professional analysts.
|24Feb17 14:44||RNS||Holding(s) in Company|
|21Feb17 15:39||RNS||Holding(s) in Company|
|30Jan17 07:00||RNS||Trading Update and Notice of Results|
|04Nov16 12:00||RNS||Holding(s) in Company|
|03Nov16 10:39||RNS||Holding(s) in Company|
|28Oct16 07:30||RNS||Completed Secondary Placing for £5.0 million|
|28Oct16 07:00||RNS||Proposed Secondary Placing and Issue of Equity|
Frequency of research reports
Research reports on
INSPIRED ENERGY PLC
INSPIRED ENERGY PLC
Upgrade to target price, shares are 25% undervalued
10 Mar 17
The shares of INSE, the energy procurement consultant, did not participate in 2016’s 25%+ AiM surge. We investigate why the shares of a company with doubledigit growth, c.40% margins and modest gearing that converts over 10% of sales into free cash, should trade at a discount to the market. We find accelerating organic growth, a decreasing risk profile and supportive macro pointers. We urge investors to consider this compelling investment case. INSE now replaces SMS.L as our top pick in our Energy Services sub-sector. We expect 25%+ upside to be realized by ongoing faultless execution by the well-respected management team.
N+1 Singer - Small-cap quantitative research - Consistent growth screen refresh + “11 with legs”
29 Sep 16
We have performed a second refresh of our consistent growth screen, first established with our research note of 17 December last year. As previously, the screen produces a basket of 25 stocks that exhibit not only good growth in EPS and sales, but also a consistency of growth in both measures each year. This basket, or style, has underperformed the small-cap benchmark by 9.1% since inception last December, and by 4.8% since the last refresh on 13 April. We highlight stocks leaving and joining the basket and take a closer look at 11 stocks “11 with legs” in the refreshed screen. We will continue to monitor performance of the basket and refresh it again in about 4 months’ time, but interestingly, consistent growth is beginning to look like consistent underperformance!
31 Aug 16
The FTSE-100 finished yesterday's session 0.25% lower at 6,820.79, whilst the FTSE AIM All-Share index closed 0.07% higher at 793.40. In continental Europe, markets ended in the green, as a weak euro led to gains in export-driven stocks, offsetting the losses in basic resource stocks. Germany's DAX and France's CAC 40 advanced 1.1% and 0.8%, respectively.
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
16 Mar 17
4imprint (FOUR): 6% dividend yield for a growth stock? (BUY) | Cambridge Cognition* (COG): Amgen uses CANTAB technology in trial (CORP) | Seeing Machines* (SEE): H1 results show steady operational progress (CORP) | Allergy Therapeutics (AGY): Pollinex Quattro Birch Ph III EU trial starts (BUY) | Capital Drilling* (CAPD): FY results in line, with turnaround in exploration activity (CORP)
N+1 Singer - N1S Trend spotting - Strategy update
08 Mar 17
In this new product we present some strategy theme updates arising out of our latest analysis of macro trends and economic data and our innovative Quant work. We also look at upcoming events and suggest topping up on some of our Best Ideas for 2017.
FY results in line, with turnaround in exploration activity
16 Mar 17
Full-year results were in-line with the recent trading update. Market conditions continue to improve, with a strong improvement in exploration activity. We make no change to our forecasts. The shares have recently seen some profit taking after a strong run, which opens a valuation opportunity as the market turnaround provides strong medium-term potential. Our 95p target price points to strong upside.
N+1 Singer - Augean - Double digit growth in ’16, good start to ‘17
21 Mar 17
Augean reported another year of double digit growth for 2016, with profits in line with our forecasts. Sales grew by 21% excluding landfill tax, while adjusted PBT grew by 18% to £7.1m before amortisation of acquired intangibles. DPS was increased by 54% to 1.0p, 25% ahead of our estimate. The business units made further strategic progress, with revenues from their top 20 customers increasing from 42% to 43% of the total, of which 88% was under contract or a framework agreement, increasing forward visibility. There has been an encouraging start to 2017 and management is confident of delivering another year of profits growth. The shares trade on undemanding single digit multiples, offering good value.